Mouse models for genetic dissection of polygenic gastrointestinal diseases

European Journal of Clinical Investigation

Volumn 33, Issue 2, 2003, Pages 155-160

  Hillebrandt, S ^a   Matern, S ^a   Lammert, Frank ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cholelithiasis; Colon cancer; Gastroschisis; Linkage analysis; Multifactorial genetics; Quantitative trait locus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CHOLELITHIASIS; COLORECTAL CANCER; ENVIRONMENTAL FACTOR; GASTROINTESTINAL DISEASE; GASTROSCHISIS; GENE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; INBRED STRAIN; LINKAGE ANALYSIS; METABOLISM; MOLECULAR CLONING; MOUSE; MULTIFACTORIAL GENETIC DISORDER; MULTIFACTORIAL INHERITANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW;

ANIMALS; CHOLELITHIASIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; GASTROSCHISIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; QUANTITATIVE TRAIT LOCI;

EID: 0037324768     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01089.x     Document Type: Review

References (61)

1. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
2. Darvasi A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 1998;18:19-24.
3. Doerge RW. Mapping and analysis of quantitative trait loci in experimental populations. Nat Rev Genet 2002;3:43-52.
4. Moore KJ, Nagle DL. Complex trait analysis in the mouse: the strengths, the limitations and the promise yet to come. Annu Rev Genet 2000;34:653-86.
5. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999;21:76-83.
6. Max M, Shanker YG, Huang L, Rong M, Liu Z et al. Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet 2001;28:58-63.
7. Lee SH, Girard S, Macina D, Busa M, Zafer A et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001;28:42-5.
8. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995;182:655-66.
9. Korstanje R, Paigen B. From QTL to gene: the harvest begins. Nat Genet 2002;31:235-6.
10. LaMont JT, Carey MC. Cholesterol gallstone formation. 2. Pathobioloiogy Pathomechanics. Prog Liver Dis 1992;10:165-91.
11. Wittenburg H, Lammert F, Wang DQ, Churchill GA, Li R et al. Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics 2002;8:67-77.
12. Wang DQ, Paigen B, Carey MC. Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice. J Lipid Res 2001;42:1820-30.
13. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQ et al. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 1995;92:7729-33.
14. Wang DQ, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 1997;38:1395-411.
15. Wang DQ, Lammert F, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion. J Lipid Res 1999;40:2066-79.
16. Lammert F, Wang DQ, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes. J Lipid Res 1999;40:2080-90.
17. Van Erpecum KJ, Wang DQ, Lammert F, Paigen B, Groen AK, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol 2001;35:444-51.
18. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-40.
19. Paigen B, Schork NJ, Svenson KL, Cheah YC, Mu JL et al. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 2000;4:59-65.
20. Bouchard G, Nelson HM, Lammert F, Rowe LB, Carey MC, Paigen B. High-resolution maps of the murine Chromosome 2 region containing the cholesterol gallstone locus, Lith1. Mamm Genome 1999;10:1070-4.
21. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-50.
22. Childs S, Yeh RL, Georges E, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res 1995;55:2029-34.
23. Figge A, Davids N, Matern S, Lammert F. Transcriptional regulation of the canalicular bile salt export pump gene (Abcb11) in gallstone-susceptible and resistant inbred mice: evidence for regulatory elements in intron1. Gastroenterology 2002;122:A7.
24. Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 2001;120:221-38.
25. Lee SP, Ko CW. Pronucleating proteins in bile - a myth? J Hepatol 2001;35:525-6.
26. Curry JI, McKinney P, Thornton JG, Stringer MD. The aetiology of gastroschisis. Br J Obstet Gynaecol 2000;107:1339-46.
27. Duhamel B. Embryology of exomphalos and allied malformations. Arch Dis Child 1963;38:142-7.
28. Hoyme HE, Jones MC, Jones KL. Gastroschisis: abdominal wall disruption secondary to early gestational interruption of the omphalomesenteric artery. Semin Perinatol 1983;7:294-8.
29. Moore T, Stokes GF. Gastroschisis. Surgery 1953;33:112-20.
30. Drongowski RA, Smith RKJ, Coran AG, Klein MD. Contribution of demographic and environmental factors to the etiology of gastroschisis: a hypothesis. Fetal Diagn Ther 1991;6:14-27.
31. Pampfer S, Streffer C. Prenatal death and malformations after irradiation of mouse zygotes with neutrons and X-rays. Teratology 1988;37:599-607.
32. Hillebrandt S, Streffer C, Müller WU. Genetic analysis of the cause of gastroschisis in the HLG mouse strain. Murat Res 1996;372:43-51.
33. Hillebrandt S, Streffer C, Montagutelli X, Balling R. A locus for radiation-induced gastroschisis on mouse Chromosome 7. Mamm Genome 1998;9:995-7.
34. Wevrick R, Francke U. An imprinted mouse transcript homologous to the human imprinted in Prader-Willi syndrome (IPW) gene. Hum Mol Genet 1997;6:325-32.
35. Layne MD, Yet SF, Maemura K, Hsieh CM, Perrella MA et al. Impaired abdominal wall development and deficient wound healing in mice lacking aortic carboxypeptidase-like protein. Mol Cell Biol 2001;21:5256-61.
36. Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991;251:1366-70.
37. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9.
38. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.
39. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;18:159-70.
40. Polakis P. More than one way to skin a catenin. Cell 2001;105:563-6.
41. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
42. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-70.
43. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9.
44. Silverman KA, Koratkar R, Siracusa LD, Buchberg AM. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res 2002;12:88-97.
45. Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH et al. The Mom1 AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 2000;19:3182-92.
46. Min-induced intestinal neoplasia. Cell 1995;81:957-66.
47. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997;17:88-91.
48. Dobbie Z, Heinimann K, Bishop DT, Muller H, Scott RJ. Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis. Hum Genet 1997;99:653-7.
49. Nimmrich I, Friedl W, Kruse R, Pietsch S, Hentsch S et al. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum Genet 1997;100:345-9.
50. Oshima M, Murai N, Kargman S, Arguello M, Luk P et al. Chemoprevention of intestinal polyposis in the Apc delta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001;61:1733-40.
51. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B et al. Suppression of intestinal polyposis in Apc deha716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
52. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2000;6:1024-8.
53. Halberg RB, Katzung DS, Hoff PD, Moser AR, Cole CE et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci USA 2000;97:3461-6.
54. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000;342:1960-8.
55. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
56. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002;122:641-5.
57. Williams C, Shattuck-Brandt RL, DuBois RN. The role of COX-2 in intestinal cancer. Ann NY Acad Sci 1999;889:72-83.
58. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-56.
59. Smits R, Ruiz P, Diaz-Cano S, Luz A, Jagmohan-Changur S et al. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology 2000;119:1045-53.
60. Takaku K, Sonoshita M, Sasaki N, Uozumi N, Doi Y et al. Suppression of intestinal polyposis in Apc (delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A (2) gene. J Biol Chem 2000;275:34013-6.
61. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.